AlTi Global Inc. Has $3.33 Million Holdings in UnitedHealth Group Incorporated $UNH

AlTi Global Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,677 shares of the healthcare conglomerate’s stock after selling 2,265 shares during the period. AlTi Global Inc.’s holdings in UnitedHealth Group were worth $3,331,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after acquiring an additional 196,696 shares during the last quarter. Nuveen LLC bought a new stake in UnitedHealth Group in the first quarter worth $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Royal Bank Of Canada reduced their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Barclays boosted their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Finally, Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Stock Down 0.3%

UNH opened at $360.48 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a market capitalization of $326.48 billion, a PE ratio of 15.62, a PEG ratio of 2.34 and a beta of 0.47. The firm’s 50 day simple moving average is $337.26 and its two-hundred day simple moving average is $340.29.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period last year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.